Eve & Co Announces Board Appointment of Ms. Shari Mogk-Edwards

TORONTO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (the “Company” or “Eve & Co”) (TSXV: EVE; OTCQB: EEVVF) is pleased to announce that Shari Mogk-Edwards has been appointed to its board of directors.

Ms. Mogk-Edwards’ previous career spans over 35 years with one of the largest single buyers of beverage alcohol in the world – the Liquor Control Board of Ontario (the “LCBO”). As the Vice President, Products, Sales and Merchandising, she led a high performance team of 100 category and inventory specialists, and directed sales of over $5B. She also developed and led VINTAGES, the fine wine department at the LCBO, to annual sales from $23M to over $500M. As a face of the LCBO, Shari managed her “Shari’s Picks” program, promoted responsible consumption, regularly represented the LCBO at trade, television and radio events, and was a key note speaker at countless events.

At her new consulting company, Ms. Mogk-Edwards is now focused on breaking down barriers and developing businesses. She shares her knowledge and experiences through her personal approach.

“We are very excited to have Shari on board. We expect her to be a very valuable asset in the direction of the EVE brand and as another female voice to authentically address and represent women and what they want from cannabis products. We believe that with Shari’s vast experience and focus on the female customer and in consumer packaged goods within a highly restrictive marketing and advertising regime, she will be a positive force in the awareness of EVE’s products and overall growth of EVE,” said Melinda Rombouts, President and Chief Executive Officer of Eve & Co.

In connection with her appointment, Ms. Mogk-Edwards was granted options to purchase up to 500,000 common shares of Eve & Co at an exercise price of $0.26 per share for a period of five years, with one third of such options vesting each year over the next three years in arrears.

Ms. Mogk-Edwards’ appointment remains subject to approval of the TSX Venture Exchange (the “TSXV”).

ABOUT EVE & CO INCORPORATED

Eve & Co, through its wholly-owned subsidiary Natural MedCo Ltd., holds cultivation and processing licenses under the Cannabis Act (Canada) for the production and sale of various cannabis products, including dried cannabis, cannabis plants and cannabis oil. Natural MedCo Ltd. was Canada’s first female founded licensed producer of medicinal marijuana and received its cultivation license from Health Canada in 2016.

Eve & Co is led by a team of agricultural experts and has a licenced 220,000 sq. ft. scalable greenhouse production facility located in Middlesex County, Ontario with 32 acres of adjacent land for future expansion. Eve & Co has commenced construction of an additional 780,000 sq. ft. proposed expansion, bringing Eve & Co’s total anticipated greenhouse capacity to 1,000,000 sq. ft.

The TSXV has neither approved nor disapproved the contents of this news release. Neither the TSXV nor its Regulation Service Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

Certain statements in this press release constitute forward-looking information. All statements other than statements of historical fact contained in this press release, including, without limitation, those regarding the Company’s expansion and funding therefor, future, strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words “believe”, “expect”, “aim”, “intend”, “plan”, “continue”, “will”, “may”, “would”, “anticipate”, “estimate”, “forecast”, “predict”, “project”, “seek”, “should” or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company’s expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict, including those described in the Company’s filing statement dated June 18, 2018 and available on the Company’s SEDAR profile. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. The forward-looking information and forward-looking statements included in this news release are made as of the date of this news release the Company does not undertake an obligation to publicly update such forward-looking information or forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities law.

For further information, please contact: